Should You Buy HYPE Token or the Stock?

The HYPE token is one of the few bright spots in crypto right now, and it comes with a choice most projects never offer: buy the token directly, or buy shares in a company that holds it. That split might sound like a minor technicality. It isn't.

What Is Hyperliquid and Why Does It Matter?

The Hyperliquid DEX is the dominant venue for perpetual futures in decentralized finance. Perpetual futures, or perps, are crypto-native derivatives that let traders speculate on asset prices without the expiration date you'd find on traditional options contracts. The platform logged $181.6 billion in trading volume over the 30 days ending May 1, 2026, a number that isn't close.

Most platforms give investors exactly one entry point: buy the token. Hyperliquid gives you two. There's the token itself, HYPE, and then there's Hyperliquid Strategies (NASDAQ: PURR), a publicly listed company whose entire business model is buying and holding HYPE. These two routes look similar on the surface but deliver very different economic exposures. Getting that distinction wrong is an expensive mistake.

HYPE Token vs. PURR Stock: What's the Real Difference?

The HYPE token runs on a buyback-and-burn mechanic that is, frankly, elegant. About 97% of all trading fees collected on the platform flow into an automated system that purchases HYPE from open markets and then permanently destroys those tokens. Less supply, same demand equals higher value per remaining token. Token holders also qualify for staking rewards and any future airdrops, neither of which passes through to PURR stockholders.

The stock side of the equation is a different animal. Hyperliquid Strategies is what the industry calls a digital asset treasury company: a corporate wrapper around a pile of tokens. As of early 2026, it held 17.6 million HYPE and $112.6 million in cash, with zero debt. It runs a $30 million share buyback program designed to prop up per-share token exposure when the stock price sags. The pitch to investors is accessibility: anyone with a standard brokerage or retirement account can buy PURR without touching a crypto wallet.

That convenience has a cost, though. Hyperliquid Strategies can issue new shares to fund token purchases, diluting existing shareholders in the process. The token's fee-driven buyback accrues directly to HYPE holders; for stock investors, that same benefit gets filtered through corporate overhead and potential dilution before it reaches them. Call it a tax on accessibility.

Token buyers face their own overhang. Only 42.5% of the total 1 billion HYPE token supply is currently circulating. Monthly unlocks of roughly 10 million tokens are scheduled to continue through October 2027. The protocol's buybacks have absorbed much of that incoming supply so far, but there's no guarantee they'll keep pace as unlock pressure builds. Buying HYPE is essentially a bet that trading volume keeps climbing fast enough to outrun the supply schedule.

So Which One Should You Actually Buy?

If you want the most direct exposure to Hyperliquid's growth, the token wins. Full stop. When fee revenue fuels buybacks, HYPE holders absorb that benefit immediately. Stockholders get it eventually, maybe, after the company's overhead takes its cut and assuming no share dilution.

The stock makes sense only for one specific type of investor: someone who cannot or will not set up a crypto wallet and needs to access this trade through a brokerage account. That's a real use case. It's just a narrower one, and it comes with structural disadvantages that the token does not have.

Neither asset is safe. Both are early, both are volatile, and both are dependent on Hyperliquid maintaining its grip on perps volume in a market where competitors are not sitting still. The question of which to buy matters less than the question of whether you should be buying at all given your risk tolerance.